AAD 2026Abstract 73380Clinical trial
Bimekizumab pharmacokinetics, safety, and efficacy in adolescents with moderate to severe plaque psoriasis
Data from the initial treatment period of the open-label BE CONNECTED phase 2 study
Paller A, Szepietowski JC, Węgłowska J, Charlton P, Staelens F, Deherder D, MacPherson M, Datye A, Pinter A
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Topics: PsoriasisPediatric dermatology
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.339 · Not in PubMed: details from Crossref